Tradestie Institutional Equity Comparison Engine

BDRX vs NEXR โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

BDRX Overall Edge

BDRX Captures Institutional Edge (1โ€“1 Pillars ยท 7โ€“0 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Biodexa Pharmaceuticals plc American Depositary Shs (BDRX) driven by superior Growth & Margin while NEXR counters with relative strength in Momentum & Technical. Fundamentally, BDRX trades at N/M Forward P/E with 0.0% operating margin (-64.1% YoY revenue) versus NEXR at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, BDRX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against NEXR sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
BDRX N/M vs NEXR N/M Fwd P/E
Growth & Margin Winner BDRX
Op Margin 0.0% vs N/A ยท YoY -64.1% vs N/A
Momentum & Technical Winner NEXR
1Y -54.1% vs -39.2% ยท 52W Pos 23% vs 23%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
BDRX NASDAQ
Biodexa Pharmaceuticals plc American Depositary Shs
Pharmaceutical Preparations
$2.35
-2.29% 1D
Market Cap $1.2M
1M Return +414.14%
1Y Return -54.11%
Forward P/E N/M
Unified AI Score
34.7 / 100 SELL
Tech 8.0 Fund 30.0 Flow 50.0 Mom 40.0
NEXR US Equity
NEXR
Institutional Equity
$1.38
-7.38% 1D
Market Cap N/A
1M Return +67.27%
1Y Return -39.21%
Forward P/E N/M
Unified AI Score
31.0 / 100 SELL
Tech 50.0 Fund 27.0 Flow 50.0 Mom 40.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: BDRX -54.11% NEXR -39.21% Spread: +318.72 pp (BDRX Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
BDRX TTM Op. Margin: 0.0% NEXR TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BDRX vs NEXR. Trailing 12-month operating profitability (BDRX 0.0% vs NEXR N/A) and valuation multiples (BDRX N/M vs NEXR N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: BDRX (7) vs NEXR (0)
Institutional Metric BDRX NEXR Criterion Row Winner
Market Capitalization Scale $1.2M N/A Larger Scale BDRX
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth -64.1% N/A Higher Growth BDRX
Operating Margin (TTM) Profitability 0.0% N/A Higher Margin BDRX
Net Profit Margin Profitability 0.0% N/A Higher Margin BDRX
Return on Equity (ROE) Capital Efficiency -42.0% N/A Higher ROE BDRX
52-Week Range Position Momentum 23% ($0โ€“$9) 23% ($0โ€“$5) Stronger Trend Tie
Beta / 30D Volatility Risk Regime 5.72ฮฒ ยท 2679% Vol 8.42ฮฒ ยท 2730% Vol Lower Realized Risk BDRX
Unified Institutional Score Composite Signal 34.7 / 100 (SELL) 31.0 / 100 (SELL) Higher Composite BDRX

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full BDRX vs NEXR Buy Guide
BDRX UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live BDRX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
NEXR UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live NEXR Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither BDRX nor NEXR registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.